Blood Test Shows Promise for Earlier ALS Detection
UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.
UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.
The accuracy of polygenic scores (PGSs) varies between individuals across a continuum of genetic ancestry.
Researchers have developed a blood test for rapid identification of placenta accreta spectrum disorder, enabling timely intervention.